BBNX · Beta Bionics, Inc. · Executive Compensation

$17.75 -3.64 (-17.02%) Q1 2026 earnings call transcript

Russell 2000 member Rebalance outlook locked

Market Cap

$962.33M

54.37M

Volume · Oct 28 2.46M Avg daily vol (3M) 1.31M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sean Saint	President and Chief Executive Officer	$700,000	—	$1,584,360	$8,981,357	$894,600	$31,000	$12,191,317
Stephen Feider	Chief Financial Officer	$475,000	—	$689,490	$3,676,312	$333,878	$23,500	$5,198,180
Mike Mensinger	Chief Product Officer	$450,000	—	$513,450	$2,341,193	$316,305	$23,251	$3,644,200

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Sean Saint	President and Chief Executive Officer	$491,667	—	—	—	$371,000	$23,000	$885,667
Stephen Feider	Chief Financial Officer	$358,333	—	—	—	$278,250	$23,000	$659,583

Executive changes

Person	Role	Change	Effective	Filed
Gerard Michel	Class III director	Appointed	2025-03-26	2025-03-27

Leadership

Sean Saint CEO, Board Member
Stephen Feider CFO
Gerard Michel Board Member

Key facts CIK 1674632 CUSIP 08659B102 13F (30d) 22 filings 22 filers Visit website Investor relations